Skip to main content
. 2018 Jun 15;9:318. doi: 10.3389/fendo.2018.00318

Figure 4.

Figure 4

Temozolomide-treated patients. Demographics, clinical presentation, previous surgeries, and radiotherapy comparing aggressive pituitary adenomas and pituitary carcinomas. Data from Ref. (77).